PetMed Express, Inc. (PETS)

PetMed Express Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	13.08	21.41	54.72	55.3	104.09	111.08
Cash & Short-Term Investments	13.08	21.41	54.72	55.3	104.09	111.08
Cash Growth	-68.20%	-60.87%	-1.04%	-46.88%	-6.30%	-6.43%
Receivables	1.71	1.91	2.32	3.28	1.74	1.91
Inventory	8.47	13.61	16.21	28.56	19.02	32.46
Prepaid Expenses	4.26	6.38	5.33	6.33	4.72	4.87
Other Current Assets	0.1	0.26	0.3	0.19	0.86	0.68
Total Current Assets	27.61	43.56	78.87	93.65	130.43	151
Property, Plant & Equipment	25.61	26.84	29.83	28.09	26.18	24.46
Long-Term Investments	-	5.3	5.3	5.3	5	-
Goodwill	-	-	26.66	26.66	-	-
Other Intangible Assets	10.55	5.49	8.05	11.2	0.86	0.86
Long-Term Deferred Tax Assets	-	-	-	4.99	5.01	3.38
Total Assets	63.76	81.19	148.7	169.88	167.48	179.7

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	12.3	20.91	23.56	37.02	25.21	27.5
Accrued Expenses	27.26	27.76	34.64	28.44	29.16	26.38
Current Portion of Leases	0.41	0.49	0.46	0.46	-	-
Current Income Taxes Payable	-	0.02	0.08	-	-	-
Current Unearned Revenue	0.63	2.63	3.77	4.45	1.66	1.62
Other Current Liabilities	-	0.23	0.25	1.78	1.48	0.75
Total Current Liabilities	40.6	52.03	62.77	72.16	57.51	56.25
Long-Term Leases	-	0.04	0.54	1	-	-
Long-Term Deferred Tax Liabilities	0.18	0.18	0.26	-	-	-
Total Liabilities	40.77	52.25	63.57	73.15	57.51	56.25

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	0.02	0.02	0.02	0.02	0.02	0.02
Additional Paid-In Capital	19.84	19.65	18.56	25.15	18.28	11.66
Retained Earnings	3.12	9.26	66.54	71.56	91.66	111.76
Total Common Equity	22.98	28.93	85.13	96.72	109.96	123.44
Shareholders' Equity	22.99	28.94	85.13	96.73	109.97	123.45
Total Liabilities & Equity	63.76	81.19	148.7	169.88	167.48	179.7

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	0.41	0.54	1	1.45	-	-
Net Cash (Debt)	12.67	20.88	53.72	53.84	104.09	111.08
Net Cash Growth	-68.53%	-61.14%	-0.22%	-48.27%	-6.30%	-6.43%
Net Cash Per Share	0.60	1.00	2.61	2.64	5.12	5.46
Filing Date Shares Outstanding	21.68	21.03	20.99	19.87	20.45	20.22
Total Common Shares Outstanding	21.68	21.05	20.64	20.45	20.33	20.21
Working Capital	-12.99	-8.47	16.1	21.49	72.92	94.75
Book Value Per Share	1.06	1.37	4.12	4.73	5.41	6.11
Tangible Book Value	12.43	23.44	50.42	58.86	109.1	122.58
Tangible Book Value Per Share	0.57	1.11	2.44	2.88	5.37	6.07
Land	-	3.7	3.7	3.7	3.7	3.7
Buildings	-	19.51	19.63	19.51	18.91	17.83
Machinery	-	9.08	9.43	9.33	9.4	9.11

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Jun 2, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 19, 2026

Data Sources Report a data error